Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer — Αngeliki Andrikopoulou (2023) | RDL Network
Gerasimos Aravantinos, Meletios A Dimopoulos, P Kosmidis, Dimitrios Bafaloukos, Christos Papadimitriou, Christos Kiamouris, N. Pavlidis, K. Sikiotis, Pavlos Papakostas, D. Skarlos
Discussion(0)
No comments yet. Be the first to comment.